Checkmate 274 trial: Is Nivolumab the new standard in adjuvant setting for high-risk muscle invasive urothelial carcinoma ?

Naveen KumarIndian Journal of Urology 2021 37(4):369-371

Source: Indian Journal of Urology - October 1, 2021 Category: Urology & Nephrology Authors: Naveen Kumar Source Type: research